Reblozyl (luspatercept)

pCPA File Number: 21506
Negotiation Status:
Active Negotiation
Indication(s):
anemia associated with beta-thalassemia
Sponsor/Manufacturer:
Celgene Inc.
CADTH Project Number:
SR0669-00
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable